Akso Health Group/$AHG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Akso Health Group
Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
Ticker
$AHG
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
9
ISIN
US98422P1084
Website
AHG Metrics
BasicAdvanced
$512M
-
-$0.05
-0.23
-
Price and volume
Market cap
$512M
Beta
-0.23
52-week high
$1.98
52-week low
$0.83
Average daily volume
19K
Financial strength
Current ratio
8.191
Quick ratio
7.502
Long term debt to equity
0.032
Total debt to equity
2.367
Profitability
Gross margin (TTM)
3.26%
Net profit margin (TTM)
-77.92%
Operating margin (TTM)
-81.17%
Effective tax rate (TTM)
-0.59%
Revenue per employee (TTM)
$940,000
Management effectiveness
Return on assets (TTM)
-3.73%
Return on equity (TTM)
-6.41%
Valuation
Price to revenue (TTM)
25.57
Price to book
1.7
Price to tangible book (TTM)
3.87
Price to free cash flow (TTM)
-55.892
Free cash flow yield (TTM)
-1.79%
Free cash flow per share (TTM)
-2.54%
Growth
Revenue change (TTM)
281.19%
Earnings per share change (TTM)
-81.32%
3-year revenue growth (CAGR)
135.47%
3-year earnings per share growth (CAGR)
-65.71%
Bulls say / Bears say
Akso Health Group's integration of DeepSeek's advanced AI technology aims to enhance its healthcare services by improving diagnostic accuracy and personalized treatment recommendations. (stocktitan.net)
The company's plan to acquire Deyihui, an online clinic, positions it to tap into the rapidly growing virtual consultation market in China, potentially expanding its service offerings and revenue streams. (stocktitan.net)
A significant decrease in short interest, down 20.4% as of February 28, 2025, may indicate increased investor confidence and reduced bearish sentiment towards the stock. (defenseworld.net)
Over the past three years, Akso Health Group's revenue has declined by an average of 5.3% per year, raising concerns about the company's ability to achieve sustainable growth. (simplywall.st)
The stock has experienced a 36% decline over the last three years, significantly underperforming the market return of approximately 25%, which may reflect ongoing operational challenges. (simplywall.st)
Renaissance Technologies LLC reduced its holdings in Akso Health Group by 8.7% during the fourth quarter, potentially signaling decreased institutional confidence in the company's prospects. (defenseworld.net)
Data summarised monthly by Lightyear AI. Last updated on 4 Jun 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Akso Health Group stock?
Akso Health Group (AHG) has a market cap of $512M as of June 20, 2025.
What is the P/E ratio for Akso Health Group stock?
The price to earnings (P/E) ratio for Akso Health Group (AHG) stock is 0 as of June 20, 2025.
Does Akso Health Group stock pay dividends?
No, Akso Health Group (AHG) stock does not pay dividends to its shareholders as of June 20, 2025.
When is the next Akso Health Group dividend payment date?
Akso Health Group (AHG) stock does not pay dividends to its shareholders.
What is the beta indicator for Akso Health Group?
Akso Health Group (AHG) has a beta rating of -0.23. This means that it has an inverse relation to market volatility.